Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2015
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2014.
Key Financial Metrics
The Form 8-K serves as a notification of a press release (Exhibit 99.1) containing the financial results. The text of this filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these details.
Material Changes
The filing text does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of results for the period ended December 31, 2014.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 11:00 AM EST on February 26, 2015, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2014.
- Verify the details of the conference call held on February 26, 2015, for management's outlook and commentary.
- Confirm whether the press release contains updated forward-looking guidance or risk factors.
- Note that the 8-K text itself does not contain the financial data, only the reference to the press release.